NasdaqGM - Nasdaq Real Time Price USD
TELA Bio, Inc. (TELA)
Tune into earnings calls Now streaming directly on quote pages.
1.0550
+0.0645
+(6.51%)
As of 2:33:38 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | -0.17 | -0.17 | -0.74 | -0.47 |
| Low Estimate | -0.19 | -0.19 | -0.86 | -0.65 |
| High Estimate | -0.16 | -0.15 | -0.59 | -0.26 |
| Year Ago EPS | -0.51 | -0.42 | -1.59 | -0.74 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | 20.87M | 22.22M | 85.75M | 105.34M |
| Low Estimate | 19.9M | 22M | 85M | 101.6M |
| High Estimate | 22M | 22.5M | 86.57M | 109.1M |
| Year Ago Sales | 16.09M | 18.96M | 69.3M | 85.75M |
| Sales Growth (year/est) | 29.70% | 17.23% | 23.74% | 22.83% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.47 | -0.42 | -0.22 | -0.21 |
| EPS Actual | -0.51 | -0.42 | -0.23 | -0.25 |
| Difference | -0.04 | -0 | -0.01 | -0.04 |
| Surprise % | -8.05% | -0.96% | -3.60% | -20.48% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.17 | -0.17 | -0.74 | -0.47 |
| 7 Days Ago | -0.18 | -0.16 | -0.68 | -0.4 |
| 30 Days Ago | -0.18 | -0.16 | -0.68 | -0.4 |
| 60 Days Ago | -0.18 | -0.18 | -0.64 | -0.25 |
| 90 Days Ago | -0.18 | -0.18 | -0.64 | -0.25 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | 2 | 1 | 3 | 1 |
| Down Last 30 Days | 2 | 1 | 3 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TELA | 65.69% | 59.52% | 53.52% | 36.94% |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Buy to Buy | 3/21/2025 |
| Maintains | Citizens Capital Markets: Market Outperform to Market Outperform | 3/21/2025 |
| Downgrade | Piper Sandler: Overweight to Neutral | 3/21/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 11/8/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 10/4/2024 |
| Maintains | Lake Street: Buy to Buy | 8/13/2024 |
Related Tickers
CVRX CVRx, Inc.
4.8150
-38.11%
SGHT Sight Sciences, Inc.
2.9700
-1.98%
AXGN Axogen, Inc.
11.40
-9.44%
SSKN STRATA Skin Sciences, Inc.
2.5300
-1.94%
SIBN SI-BONE, Inc.
18.51
+0.95%
SONX Sonendo, Inc.
1.0300
-26.43%
ELUT Elutia Inc.
1.8300
-8.04%
OFIX Orthofix Medical Inc.
12.36
+0.37%
ESTA Establishment Labs Holdings Inc.
33.95
-2.44%
VTAK Catheter Precision, Inc.
0.2801
+7.73%